Europe Wearable Medical Devices Market Analysis and Forecast 2026-2034

Europe Wearable Medical Devices Market

Europe Wearable Medical Devices Market is expected to grow from US$ 13.02 Billion in 2025 to US$ 42.68 Billion by 2034, expanding at a Compound Annual Growth Rate (CAGR) of 14.10% during 2026-2034. Market growth is driven by the rising prevalence of chronic diseases, increasing adoption of remote patient monitoring, and growing demand for connected healthcare solutions. Technological advancements in wearable sensors, artificial intelligence, and digital health platforms, along with supportive healthcare initiatives, are further accelerating market expansion across Europe.

Europe Wearable Medical Devices Market Overviews

Wearable medical devices are smart electronic healthcare devices designed to be worn on the body to continuously monitor, detect, and manage various health conditions in real time. Equipped with advanced sensors, wireless connectivity, and data analytics capabilities, these devices collect physiological information such as heart rate, blood pressure, blood oxygen levels, glucose levels, sleep patterns, body temperature, and physical activity. The collected data can be shared with healthcare professionals through mobile applications or cloud-based platforms, enabling remote patient monitoring and timely medical intervention. Common wearable medical devices include smartwatches with health monitoring features, continuous glucose monitors (CGMs), wearable ECG monitors, blood pressure monitors, fitness trackers, and wearable cardiac patches.

In Europe, wearable medical devices are becoming increasingly popular due to the growing burden of chronic diseases, aging populations, and the expansion of digital healthcare services. Hospitals, healthcare providers, and patients are adopting these devices to improve disease management, reduce hospital admissions, and support preventive healthcare. Government initiatives promoting telemedicine, remote patient monitoring, and digital health transformation, along with increasing consumer awareness of personal health and wellness, continue to drive strong demand for wearable medical devices across residential and clinical settings throughout Europe.

EU Pushes for Unified Strategy Against Rising Heart Disease

The European Commission has released new guidelines to help EU countries strengthen prevention, screening, and treatment of cardiovascular disease. It includes a call for national heart-health plans by 2027.

The framework, known as the Safe Hearts Plan, sets out nonbinding recommendations organized around three areas: prevention, early detection, and treatment and care, including rehabilitation. The Commission says the guidance is intended to help member states develop or update national cardiovascular strategies.

Cardiovascular disease remains the leading cause of illness and death in the EU, accounting for 1 in 3 deaths, according to a 2025 report from the Organisation for Economic Co-Operation and Development. The burden is expected to grow substantially, with prevalence projected to increase by 90% between 2025 and 2050 and deaths by 73% over the same period.

Wearable Medical Device Launches, approvals, and healthcare initiatives in Europe

UK Medicines and Medical Devices (MMD) Access Initiative - United Kingdom (February 2025)

The National Institute for Health and Care Excellence (NICE) launched the Medicines and Medical Devices (MMD) Access Initiative to accelerate patient access to innovative wearable medical devices and digital health technologies through streamlined evaluation processes.

AIKON Health Launch - Netherlands (September 2023)

The Netherlands Organisation for Applied Scientific Research (TNO) launched AIKON Health, a digital health company focused on developing wearable medical devices for continuous monitoring of patients with chronic diseases.

ThrombUS+ Wearable DVT Monitoring Project - Greece (June 2024)

The Horizon Europe-funded ThrombUS+ project was launched to develop a wearable point-of-care device for continuous monitoring and early detection of deep vein thrombosis (DVT), involving research partners from multiple European countries.

WHOOP 5.0 and WHOOP MG - Europe Availability (May 2025)

WHOOP introduced the WHOOP 5.0 and WHOOP MG wearables featuring ECG heart screening, blood pressure insights, Healthspan analytics, and a redesigned health monitoring platform for consumers and healthcare users.

European CE Certifications for Wearable Medical Devices (2024)

Market Catalysts in the Europe Wearable Medical Devices Market

Rising Prevalence of Chronic Diseases and Aging Population

The increasing prevalence of chronic diseases and Europe's rapidly aging population are major factors driving the wearable medical devices market. Conditions such as cardiovascular disease, diabetes, hypertension, respiratory disorders, and obesity require continuous monitoring to improve treatment outcomes and reduce healthcare costs. Wearable medical devices enable real-time tracking of vital signs, blood glucose levels, heart rhythm, oxygen saturation, and physical activity, allowing patients and healthcare providers to detect abnormalities early and intervene promptly. Europe has one of the world's largest elderly populations, creating growing demand for remote health monitoring solutions that support independent living while reducing hospital admissions. Governments and healthcare organizations are increasingly encouraging preventive healthcare and home-based patient management to address rising healthcare expenditures. As patients become more proactive about managing their health and clinicians seek efficient monitoring tools, wearable medical devices are becoming an essential component of chronic disease management, contributing significantly to sustained market growth across Europe.

Expansion of Digital Healthcare and Remote Patient Monitoring

Europe's accelerating adoption of digital healthcare technologies is significantly boosting demand for wearable medical devices. Governments and healthcare providers are investing in telemedicine, connected healthcare platforms, and remote patient monitoring programs to improve healthcare accessibility and reduce pressure on hospitals. Wearable devices continuously collect health data and securely transmit it to physicians through smartphones and cloud-based platforms, enabling timely diagnosis and personalized treatment without requiring frequent hospital visits. The widespread adoption of electronic health records (EHRs), artificial intelligence, and Internet of Medical Things (IoMT) technologies further enhances the effectiveness of wearable healthcare solutions. Remote monitoring has become increasingly important for managing chronic diseases, post-operative recovery, elderly care, and preventive healthcare. Growing patient acceptance of digital health services and supportive reimbursement initiatives across several European countries are encouraging wider adoption of medical wearables. These technological advancements are transforming healthcare delivery while creating substantial opportunities for market expansion throughout the region.

Technological Advancements and Increasing Consumer Health Awareness

Rapid innovation in wearable technology is driving the Europe wearable medical devices market by improving device accuracy, comfort, and functionality. Manufacturers are introducing advanced biosensors, artificial intelligence, machine learning algorithms, flexible electronics, and wireless communication technologies that enable continuous and highly accurate health monitoring. Modern wearable medical devices can monitor multiple health parameters simultaneously while providing real-time alerts for potential medical emergencies. Integration with smartphone applications and cloud platforms allows users to track their health trends and share medical information with healthcare professionals. At the same time, growing consumer awareness of preventive healthcare, fitness, and personal wellness is encouraging wider adoption of wearable devices beyond traditional clinical settings. Consumers are increasingly seeking products that support early disease detection, healthy lifestyles, and personalized healthcare management. Continuous product innovation, combined with increasing digital literacy and demand for convenient healthcare solutions, continues to strengthen the long-term growth prospects of Europe's wearable medical devices market.

Challenges in the Europe Wearable Medical Devices Market

Data Privacy, Cybersecurity, and Regulatory Compliance

Data privacy and cybersecurity remain significant challenges for the Europe wearable medical devices market. These devices continuously collect sensitive personal health information that must be securely stored, transmitted, and processed. Compliance with the European Union's General Data Protection Regulation (GDPR) and Medical Device Regulation (MDR) requires manufacturers to implement rigorous security measures, obtain regulatory approvals, and maintain strict data governance standards. Cybersecurity risks such as unauthorized access, hacking, and data breaches can undermine patient trust and create legal liabilities for healthcare providers and manufacturers. Additionally, obtaining regulatory approval for wearable medical devices can be time-consuming and costly due to extensive clinical testing, safety evaluations, and documentation requirements. Smaller companies may face difficulties meeting these regulatory standards, slowing innovation and market entry. Addressing cybersecurity concerns, strengthening data protection measures, and ensuring ongoing regulatory compliance will remain essential for sustaining consumer confidence and supporting continued market growth across Europe.

High Device Costs and Limited Reimbursement Coverage

The relatively high cost of advanced wearable medical devices remains a key barrier to broader market adoption across Europe. Devices equipped with sophisticated sensors, artificial intelligence, continuous monitoring capabilities, and wireless connectivity often involve significant development and manufacturing expenses, resulting in premium pricing. Although wearable medical devices can reduce long-term healthcare costs through early diagnosis and remote monitoring, the initial investment may discourage individual consumers and smaller healthcare providers. Reimbursement policies for wearable medical devices also vary considerably across European countries, limiting patient access in certain healthcare systems. Inconsistent insurance coverage and reimbursement eligibility create uncertainty for both manufacturers and healthcare providers when promoting new technologies. Furthermore, healthcare organizations may face budget constraints that delay large-scale implementation of remote monitoring programs. Expanding reimbursement frameworks, reducing manufacturing costs through technological advancements, and demonstrating long-term clinical and economic benefits will be critical to increasing adoption and supporting sustainable growth of the European wearable medical devices market.

Europe Wearable Medical Diagnostic Devices Market

The Europe wearable medical diagnostic devices market is expanding rapidly as healthcare providers increasingly adopt continuous monitoring technologies for early disease detection and remote patient management. Devices such as wearable ECG monitors, continuous glucose monitors, blood pressure monitors, pulse oximeters, and cardiac patches enable real-time collection of critical health data, allowing clinicians to identify abnormalities before they develop into serious medical conditions. These diagnostic wearables improve treatment outcomes by supporting faster clinical decisions while reducing unnecessary hospital visits and healthcare costs.

Europe Wearable Headband Medical Devices Market

The Europe wearable headband medical devices market is witnessing steady growth due to increasing demand for non-invasive neurological monitoring, sleep assessment, and mental health management solutions. These advanced headbands incorporate electroencephalography (EEG) sensors that monitor brain activity, sleep quality, cognitive performance, stress levels, and neurological disorders in real time. Healthcare professionals are increasingly utilizing these devices to support diagnosis and long-term management of conditions such as epilepsy, insomnia, anxiety, and cognitive impairment. Growing public awareness of mental wellness and preventive neurological care has accelerated adoption across both clinical and home healthcare settings. Countries including Sweden, France, and Germany are investing in digital neurotechnology research, encouraging innovation in wearable brain-monitoring devices.

Europe Wearable Shoe Sensors Medical Devices Home Healthcare Market

The Europe wearable shoe sensors medical devices home healthcare market is growing steadily as healthcare systems increasingly adopt smart mobility monitoring solutions for elderly care, rehabilitation, and chronic disease management. Embedded pressure sensors and motion detection technologies continuously analyze gait, balance, walking patterns, and physical activity, enabling early identification of mobility disorders, fall risks, neurological diseases, and post-operative recovery complications. Countries such as the Netherlands, Italy, and Germany are incorporating these innovative devices into physiotherapy, elderly care, and remote patient monitoring programs. Integration with mobile applications and digital health platforms allows caregivers and clinicians to monitor patient progress remotely. Growing investment in smart healthcare technologies continues to strengthen the adoption of wearable shoe sensor medical devices across Europe.

Europe Online Sports and Fitness Wearable Medical Devices Market

The Europe online sports and fitness wearable medical devices market is expanding rapidly as consumers increasingly seek devices that combine fitness tracking with advanced medical monitoring capabilities. Modern wearable devices now offer medical-grade features including electrocardiogram (ECG) monitoring, blood oxygen measurement, heart rhythm analysis, sleep monitoring, and activity tracking alongside traditional fitness functions. The rapid growth of e-commerce platforms has improved product accessibility, enabling consumers to purchase connected health devices and integrate them with digital healthcare services. Growing awareness of preventive healthcare, wellness management, and personalized fitness has accelerated adoption across Europe.

United Kingdom Wearable Medical Devices Market

The United Kingdom wearable medical devices market is expanding rapidly, driven by healthcare digitalization, increasing telemedicine adoption, and growing demand for remote patient monitoring solutions. The National Health Service (NHS) continues to promote digital healthcare initiatives that encourage the integration of wearable technologies into routine clinical practice. Devices such as smart insulin pens, wearable ECG monitors, continuous glucose monitors, and biosensors are increasingly used to manage chronic diseases, improve treatment outcomes, and reduce hospital admissions.In February 2025, the National Institute for Health and Care Excellence (NICE) launched the Medicines and Medical Devices (MMD) Access Initiative to accelerate patient access to innovative medical technologies through streamlined evaluation processes. Strong regulatory standards and data protection frameworks continue to strengthen consumer confidence in wearable healthcare technologies.

Netherlands Wearable Medical Devices Market

The Netherlands wearable medical devices market is experiencing strong growth, supported by advanced healthcare infrastructure, widespread digital health adoption, and government initiatives promoting remote patient care. The country has become a leading center for digital healthcare innovation, with increasing use of wearable technologies for diabetes management, cardiac monitoring, elderly care, and chronic disease management. Dutch healthcare providers actively incorporate wearable health data into personalized treatment plans, improving patient outcomes through continuous monitoring and early intervention. Government support for eHealth, telemedicine, and home healthcare programs has further accelerated market adoption. Collaboration among universities, research institutions, hospitals, and health technology startups continues to drive innovation in wearable medical devices.

Greece Wearable Medical Devices Market

The Greece wearable medical devices market is steadily expanding as the country modernizes its healthcare system and increases investment in digital health technologies. Growing demand for remote patient monitoring, elderly care solutions, and chronic disease management has encouraged wider adoption of wearable devices such as smartwatches, blood pressure monitors, continuous glucose monitors, and cardiac monitoring systems. Government initiatives supported by European Union funding are helping accelerate healthcare digitalization and improve access to innovative medical technologies across the country. Rising public awareness of preventive healthcare and telemedicine is also contributing to increasing market demand. Healthcare providers are gradually integrating wearable technologies into patient care to improve disease management and reduce healthcare costs..

Research Methodology of Europe Wearable Medical Devices Market

The Europe Wearable Medical Devices Market was estimated using a combination of bottom-up and top-down approaches, secondary research, device shipment analysis, installed-base assessment, patient-volume analysis, average selling price estimation, company-level revenue analysis, and data triangulation. The methodology considered wearable medical devices used for continuous, intermittent, or remote monitoring of patients and physiological parameters across hospitals, clinics, home healthcare, and other healthcare settings.

1. Market Definition and Scope

The market was first defined to establish which wearable medical devices and revenues were included.

The Europe Wearable Medical Devices Market was considered to include medical-grade wearable devices designed to monitor, measure, record, transmit, or support the management of physiological and clinical parameters.

2. Secondary Research

Extensive secondary research was conducted to establish the fundamental market variables.

Information was collected from:

• European healthcare authorities
• National health ministries
• European medical-device organizations
• Regulatory agencies
• Healthcare databases
• Hospitals
• Medical associations
• Wearable medical-device manufacturers
• Distributors
• Company annual reports
• Investor presentations, etc.

The research focused on:

• Device installations
• Device shipments
• Patient adoption
• Disease prevalence
• Wearable monitoring utilization, etc.

3. Bottom-Up Market Estimation

A bottom-up approach was used as the primary market-sizing methodology.

The market was estimated by determining the number of wearable medical devices sold or actively used and multiplying the volume by the average realized selling price.

The basic calculation was:

Number of Wearable Medical Devices Sold X Average Selling Price per Device = Market Revenue

The calculation was performed separately by:

• Product
• Site
• Application
• Country

The individual estimates were then aggregated to determine the overall European market.

4. Device Shipment Analysis

Annual device shipments were estimated using manufacturer disclosures, distributor information, procurement records and healthcare facility purchases.

The analysis considered:

• New device purchases
• Replacement devices
• First-time installations
• Hospital procurement
• Home-use devices
• Remote patient monitoring programs
• Direct-to-consumer medical devices where applicable

The calculation was:

Annual Device Shipments X Average Selling Price = Annual Device Revenue

5. Installed-Base Estimation

The installed base of wearable medical devices was estimated to understand the existing user population and replacement demand.

The calculation followed:

Previous Installed Base + New Device Additions - Retired/Inactive Devices = Current Installed Base

The model considered:

• Device lifespan
• Replacement cycles
• Patient discontinuation
• Technology upgrades
• Device failure
• Reimbursement changes
• Product obsolescence

The installed base was used as a supporting indicator rather than simply equating installed devices with annual market revenue.

6. Patient-Based Estimation

A patient-based approach was used to validate device demand.

The relevant patient population was estimated for diseases and conditions where wearable medical devices were commonly used.

The calculation was:

Eligible Patient Population X Wearable Device Adoption Rate X Average Devices per Patient X Average Device Price

The methodology considered patient groups with:

• Diabetes
• Cardiovascular conditions
• Hypertension
• Respiratory disorders
• Neurological conditions
• Chronic diseases requiring remote monitoring

This approach helped validate device demand where shipment information was incomplete.

7. Continuous Glucose Monitoring Estimation

The continuous glucose monitoring segment was assessed separately.

The analysis considered:

• Number of diabetes patients
• Patients eligible for continuous glucose monitoring
• CGM adoption
• Sensors used per patient
• Sensor replacement frequency
• Average sensor price
• Receiver or transmitter requirements

The calculation was:

CGM Users X Average Sensors Used per Year X Average Sensor Price

Where applicable, transmitter and receiver revenues were calculated separately.

This approach captured the recurring nature of CGM sensor consumption.

8. Cardiac Wearable Estimation

Wearable cardiac monitoring was estimated based on:

• Number of patients requiring cardiac monitoring
• Holter monitoring
• ECG patches
• Remote cardiac monitoring
• Wearable ECG devices
• Average monitoring duration
• Device replacement

The calculation was:

Eligible Cardiac Monitoring Patients X Wearable Adoption Rate X Average Revenue per Device/Monitoring Episode

Hospital and ambulatory cardiac monitoring were analyzed separately where pricing structures differed.

9. Blood Pressure and Other Vital-Sign Wearables

Wearable blood pressure, pulse oximetry, temperature, and respiratory monitoring devices were assessed using patient and healthcare-facility demand.

The analysis considered:

• Number of eligible patients
• Device adoption
• Device replacement
• Monitoring frequency
• Average selling price

The calculation was:

Eligible Users X Adoption Rate X Average Devices per User X Average Selling Price

10. Remote Patient Monitoring Analysis

Remote patient monitoring was assessed as an important demand channel for wearable medical devices.

The analysis considered:

• Hospitals
• Home healthcare providers
• Telehealth providers
• Chronic disease management programs
• Remote monitoring platforms

The calculation was:

Remote Monitoring Patients X Wearable Device Utilization X Average Revenue per Patient/Device

Where service fees and device revenue were bundled, the device component was isolated to prevent double counting.

11. Hospital and Healthcare-Facility Estimation

Healthcare facilities were assessed to determine institutional demand.

The analysis considered:

• Number of hospitals
• Number of monitored patients
• Number of wearable devices per facility
• Device replacement cycles
• Procurement expenditure
• Remote monitoring programs

The calculation was:

Healthcare Facilities X Average Wearable Devices per Facility X Average Device Price

Large hospitals and specialist centers were assessed separately where sufficient data were available.

12. Home Healthcare Estimation

Home-based wearable medical devices were estimated separately.

The analysis considered:

• Chronic disease management
• Elderly patient monitoring
• Post-discharge monitoring
• Home healthcare services
• Telemedicine
• Remote patient monitoring

The calculation was:

Home-Monitoring Patients X Wearable Adoption Rate X Average Device Revenue per Patient

Recurring consumables were treated separately from reusable devices.

13. Average Selling Price Estimation

Average selling prices were estimated separately according to:

• Device type
• Technology
• Country
• Healthcare setting
• Medical application
• Reusable versus disposable device
• Subscription versus one-time purchase

Pricing information was obtained from:

• Manufacturers
• Distributors
• Hospital procurement records
• Public tenders
• Healthcare providers
• Reimbursement schedules
• Product catalogs
• Industry interviews

The model used average realized prices rather than relying exclusively on listed retail prices.

14. Recurring Consumables Analysis

Some wearable medical devices required recurring consumables.

This was particularly important for:

• Continuous glucose monitoring sensors
• Disposable ECG patches
• Single-use monitoring patches
• Wearable biosensor components
• Replacement electrodes

The calculation was:

Number of Users X Annual Consumable Usage per User X Average Consumable Price

Recurring consumables were included only when they fell within the defined market scope.

15. Reimbursement Analysis

European reimbursement structures were analyzed because coverage varied between countries.

The assessment considered:

• National healthcare systems
• Statutory health insurance
• Private insurance
• Hospital reimbursement
• Remote monitoring reimbursement
• Patient out-of-pocket expenditure

The calculation was:

Reimbursed Devices X Average Reimbursement per Device

Reimbursement information was used to validate realistic adoption and realized pricing.

16. Country-Level Market Estimation

Each major European market was estimated independently.

For each country, the analysis considered:

Population -> Eligible Patients -> Device Adoption -> Device Volume -> Average Price -> Market Revenue

The individual country estimates were then aggregated to determine the Europe-wide market.

17. Company-Level Revenue Analysis

Major wearable medical-device manufacturers were identified and analyzed.

The assessment considered companies involved in:

• Continuous glucose monitoring
• Cardiac monitoring
• Remote patient monitoring
• Wearable biosensors
• Wearable ECG
• Medical smartwatches
• Patient monitoring systems

Company annual reports, product portfolios, geographic revenues, regulatory approvals, and device sales were reviewed.

Where companies generated revenue from both medical and consumer wearable products, only the estimated medical-device portion was included.

18. Product-Level Analysis

Individual wearable medical devices were reviewed to validate:

• Product type
• Medical indication
• Sensor technology
• Wear location
• Reusable or disposable format
• Regulatory approval
• Geographic availability
• Device price
• Replacement frequency

Product-level analysis helped establish realistic average selling prices and technology-specific adoption assumptions.

19. Top-Down Market Estimation

A top-down approach was applied as an independent validation method.

The broader European medical devices market and relevant patient-monitoring segments were assessed first. The proportion attributable to wearable medical devices was then estimated.

The calculation was:

Relevant European Medical Device/Patient Monitoring Market X Wearable Medical Device Share = Estimated Market

The wearable share was determined using:

• Device shipments
• Installed base
• Patient adoption
• Remote monitoring utilization
• Wearable technology penetration

The resulting estimate was compared with the bottom-up calculation.

20. Supply-Side Validation

The supply side was analyzed through manufacturers and distributors.

The assessment considered:

• Wearable medical-device revenues
• Device shipments
• Product portfolios
• Manufacturing capacity
• Distribution networks
• Regional sales
• New product launches

The aggregated supplier-side estimate was compared with the demand-side calculation.

21. Demand-Side Validation

Demand was validated through patient populations and healthcare utilization.

The calculation followed:

Patient Population -> Eligible Users -> Device Adoption -> Device Usage -> Device Revenue

The demand-side estimate was compared with:

• Device shipments
• Hospital procurement
• Manufacturer revenue
• Reimbursement data
• Patient monitoring activity

22. Avoiding Double Counting

Particular attention was given to avoiding overlap between:

• Device sales
• Sensor sales
• Consumables
• Monitoring services
• Software
• Subscription fees
• Manufacturer revenue
• Healthcare-provider revenue

For example, if a remote monitoring service included both a wearable device and a monitoring subscription, the device component was isolated when the market was defined as device revenue.

Similarly, disposable sensors were not counted twice through both manufacturer sales and healthcare-provider purchases.

23. Forecast Estimation

The historical market estimate was used as the foundation for forecasting.

Future market development was assessed based on:

• Increasing chronic disease prevalence
• Growth of remote patient monitoring
• Expansion of home healthcare
• Increasing adoption of continuous glucose monitoring
• Growth in cardiac monitoring
• Development of wearable biosensors
• Integration of AI with wearable monitoring
• Expansion of telehealth
• Increasing healthcare digitization
• Aging European population
• Greater emphasis on preventive and continuous monitoring

Separate assumptions were applied to major product categories and European countries.

24. Data Triangulation

The final Europe Wearable Medical Devices Market estimate was established through three principal approaches:

Bottom-Up Approach

Device Volume X Average Selling Price

Top-Down Approach

Relevant European Medical Device/Patient Monitoring Market X Wearable Device Share

Supply-Side Validation

Company Revenue + Device Shipments + Installed Base

The three estimates were compared and reconciled.

Where discrepancies occurred, assumptions relating to device adoption, patient populations, shipment volumes, pricing, replacement cycles, and reimbursement were reassessed.

25. Final Market Calculation

The final estimate was validated against device shipment volumes, installed-base calculations, patient populations, replacement demand, manufacturer revenues, hospital procurement, reimbursement information, average selling prices, country-level estimates and top-down market calculations.

Market Segmentation

Product

• Diagnostic Devices
• Therapeutic Devices

Site

• Strap/Clip/Bracelet
• Headband
• Shoe Sensors
• Handheld
• Others

Application

• Home Healthcare
• Sports and Fitness
• Remote Patient Monitoring

Distribution Channel

• Online Distribution
• Retail Pharmacies
• Hypermarkets
• Others

Countries

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Russia
• Poland
• Greece
• Norway
• Romania
• Portugal
• Rest of Europe

All the Key players have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Abbott Laboratories
• Activinsights Ltd
• Fitbit, Inc.
• Garmin Ltd.
• Intelesens Ltd.
• Koninklinje Philips NV
• Nuubo
• Omron Corporation
• Polar Electro Oy